يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Lutetium/therapeutic use [MeSH]"', وقت الاستعلام: 0.28s تنقيح النتائج
  1. 1
    Academic Journal
    177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)

    المؤلفون: Khreish, Fadi, Ghazal, Zaidoon, Marlowe, Robert J., Rosar, Florian, Sabet, Amir, Maus, Stephan, Linxweiler, Johannes, Bartholomä, Mark, Ezziddin, Samer

    المصدر: http://lobid.org/resources/99370678071406441#!, 49(3):1075-1085.

    مصطلحات موضوعية: Heterocyclic Compounds, 1-Ring/adverse effects [MeSH], Prostatic Neoplasms, Castration-Resistant/pathology [MeSH], Aged [MeSH], Humans [MeSH], Prospective Studies [MeSH], Prostate-Specific Antigen [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Everyday practice, Lutetium/therapeutic use [MeSH], Original Article, Metastatic castration-resistant prostate cancer (mCRPC), Lutetium-177-PSMA-617 radioligand therapy (, Male [MeSH], “Real-world” data, Dipeptides/adverse effects [MeSH], Radioisotopes [MeSH], Prostate-specific membrane antigen (PSMA), Registries [MeSH], Castration-Resistant/radiotherapy [MeSH]

    Relation: https://repository.publisso.de/resource/frl:6451485; https://doi.org/10.1007/s00259-021-05525-7; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803625/

    الاتاحة: https://repository.publisso.de/resource/frl:6451485
    https://doi.org/10.1007/s00259-021-05525-7
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803625/

    View record in BASE

    أضف إلى المفضلة
  2. 2
    Academic Journal
    Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177Lu-labeled prostate-specific membrane antigen

    المؤلفون: Huang, Kai, Schatka, Imke, Rogasch, Julian M. M., Lindquist, Randall L., De Santis, Maria, Erber, Barbara, Radojewski, Piotr, Brenner, Winfried, Amthauer, Holger

    المصدر: http://lobid.org/resources/99370676563706441#!, 35(3):314-320.

    مصطلحات موضوعية: Glutamate Carboxypeptidase II/metabolism [MeSH], Prostatic Neoplasms, Castration-Resistant/pathology [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Radioligand therapy, Treatment Outcome [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Antigens, Surface/metabolism [MeSH], Predictive score, Lutetium/therapeutic use [MeSH], Original Article, Male [MeSH], Radioisotopes/therapeutic use [MeSH], Metastatic castration-resistant prostate cancer, Castration-Resistant/radiotherapy [MeSH]

    Relation: https://repository.publisso.de/resource/frl:6471492; https://doi.org/10.1007/s12149-020-01567-3; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902572/

    الاتاحة: https://repository.publisso.de/resource/frl:6471492
    https://doi.org/10.1007/s12149-020-01567-3
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902572/

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء